Join Our 20,000+ Subscribers. Get Weekly News Sent To Your Email
Subscribe to our newsletter and stay updated on the latest Critical Care Medicine related news.
See Past Critical Care Newsletter issues

Subscribe to Newsletter

Rivaroxaban associated with increased bleeding risk compared with dabigatran in nonvalvular atrial fibrillation

2minutemedicine.com October 4, 2016

There was a total of 52 240 new starts of dabigatran and 66 651 new starts of rivaroxaban during the study period. Rivaroxaban was associated with a non-significant decrease in thromboembolic stroke. There was also a non-significant increase in mortality associated with rivaroxaban.

anticoagulation atrial fibrillation mortality risk stroke study

Prognostic Predictor Using Lactate-to-Albumin Ratio in Patients with Cirrhosis and Sepsis

Mortality Predictor with sPAP in Elderly Critically Ill with Severe COVID-19 Pneumonia

Low Decent Work Perception Among PICU Nurses

Diastolic Dysfunction Increases AKI Rick in COVID-19 Patients

Introduction to Hemodynamics

Technology in the ICU, An Issue of Critical Care Nursing Clinics of North America

Turn the Lights On!: A Physician’s Personal Journey from the Darkness of Traumatic Brain Injury (TBI) to Hope, Healing, and Recovery

Metabolic Acidosis: A Guide to Clinical Assessment and Management

Pulmonary Hypertension: Basic Science to Clinical Medicine

The Language of Kindness

Endovascular Resuscitation and Trauma Management

ICU Protocols: A Step-wise Approach, Vol II

Sepsis: Clinical Diagnosis and Treatment

Fast-Track in Cardiac Anesthesia: Cardiac Surgery in the Era of ERAS

COVID-19 and the Cardiovascular System: From Pathophysiology to Clinical Management

Ethics in Intensive Care Medicine (Lessons from the ICU)

The Infectious Disease Diagnosis: A Case Approach

Mechanical Ventilation in Patient with Respiratory Failure